Ken Fisher Viridian Therapeutics, Inc.\De Transaction History
Fisher Asset Management, LLC
- $247 Billion
- Q4 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Fisher Asset Management, LLC holds 518,027 shares of VRDN stock, worth $9.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
518,027
Previous 494,924
4.67%
Holding current value
$9.49 Million
Previous $11.3 Million
11.8%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VRDN
# of Institutions
187Shares Held
77.7MCall Options Held
581KPut Options Held
439K-
Black Rock Inc. New York, NY4.77MShares$87.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$80.9 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$71.1 Million9.15% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.75MShares$68.7 Million3.15% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.45MShares$63.1 Million12.74% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $730M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...